Showing results (11-20 of 31) with videos related to

Sort By:
Pageof 4
Plos One|August 23, 2011
Mechanisms of resistance to decitabine in the myelodysplastic syndromeTaichun Qin, Ryan Castoro, Samih El Ahdab, et al.
Blood|June 5, 2008
Aberrant CpG island methylation in acute myeloid leukemia is accentuated at relapseHeike Kroeger, Jaroslav Jelinek, Marcos R H Estécio, et al.
Epigenetics|February 19, 2016
Differentially methylated genes and androgen receptor re-expression in small cell prostate carcinomasBrittany Kleb, Marcos R H Estécio, Jiexin Zhang, et al.
Plos One|July 16, 2011
Aberrant DNA methylation is associated with disease progression, resistance to imatinib and shortened survival in chronic myelogenous leukemiaJaroslav Jelinek, Vazganush Gharibyan, Marcos R H Estecio, et al.
Cellular & Molecular Immunology|April 22, 2026
EZH2 and intracellular Ca<sup>2+</sup> signals interdependently coordinate alloreactive and CAR-T-cell responsesYing Wang, Qingrong Huang, Yan Zhou, et al.
Gastroenterology|November 12, 2013
Colorectal carcinomas with CpG island methylator phenotype 1 frequently contain mutations in chromatin regulatorsTomomitsu Tahara, Eiichiro Yamamoto, Priyanka Madireddi, et al.
Cancer Research|January 4, 2014
Fusobacterium in colonic flora and molecular features of colorectal carcinomaTomomitsu Tahara, Eiichiro Yamamoto, Hiromu Suzuki, et al.
Cancer|April 14, 2026
A phase 1 study of ASTX727 plus talazoparib in patients with triple-negative or hormone resistant/HER2-negative metastatic breast cancerKathy D Miller, Alexandra Thomas, Sandra Althouse, et al.
Genome Research|August 19, 2010
Genome architecture marked by retrotransposons modulates predisposition to DNA methylation in cancerMarcos R H Estécio, Juan Gallegos, Céline Vallot, et al.
Plos One|August 20, 2011
Frequent alteration of MLL3 frameshift mutations in microsatellite deficient colorectal cancerYoshiyuki Watanabe, Ryan J Castoro, Hyun Soo Kim, et al.
Pageof 4